Nanalysis Scientific Corp. (CVE:NSCI) Director Sean Edward Krakiwsky Purchases 50,000 Shares

Nanalysis Scientific Corp. (CVE:NSCI) Director Sean Edward Krakiwsky purchased 50,000 shares of the firm’s stock in a transaction that occurred on Monday, September 16th. The stock was purchased at an average price of C$0.38 per share, with a total value of C$19,000.00.

Nanalysis Scientific Trading Up 6.7 %

CVE:NSCI opened at C$0.40 on Wednesday. The company has a market cap of C$45.22 million, a PE ratio of -3.33 and a beta of 0.74. The business’s 50 day moving average is C$0.40 and its two-hundred day moving average is C$0.42. The company has a quick ratio of 1.11, a current ratio of 1.42 and a debt-to-equity ratio of 71.72. Nanalysis Scientific Corp. has a 52 week low of C$0.33 and a 52 week high of C$0.60.

Nanalysis Scientific Company Profile

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.